Bausch Health Provides Company Update At The 37th Annual J.P. Morgan Healthcare Conference
LAVAL, Quebec, Jan. 7, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") announced today it has published the presentation that Chairman and Chief Executive Officer Joseph C. Papa is scheduled to present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, today, Monday, Jan. 7, 2019, at 2:00 p.m. PST (5:00 p.m. EST).
Entitled "Pivoting to Offense," the presentation provides an overview of the Company's recent performance and accomplishments in its transformation and offers insight into future catalysts. The presentation is available on the Investor Relations page of the Bausch Health Companies Inc. web site at: http://ir.bauschhealth.com/events-and-presentations/2019.
About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com.
This news release may contain forward-looking statements, which may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in the Company's most recent annual or quarterly report and detailed from time to time in the Company's other filings with the Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. In addition, certain material factors and assumptions have been applied in making these forward-looking statements, including that the risks and uncertainties outlined above will not cause actual results or events to differ materially from those described in these forward-looking statements. The Company believes that the material factors and assumptions reflected in these forward-looking statements are reasonable, but readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch Health undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.
(877) 281-6642 (toll free)
View original content to download multimedia:http://www.prnewswire.com/news-releases/bausch-health-provides-company-update-at-the-37th-annual-jp-morgan-healthcare-conference-300773536.html
SOURCE Bausch Health Companies Inc.
Company Codes: NYSE:BHC, Toronto:BHC